Alterations of plasma high-density lipoprotein cholesterol levels associated with consumption of selected medications. The Lipid Research Clinics Program Prevalence Study

Circulation. 1980 Nov;62(4 Pt 2):IV77-82.

Abstract

From the 10 North American study populations of the Lipid Research Clinics Program, mean levels of plasma high-density (HDL) cholesterol were contrasted between users of eight categories of prescribed medications and a control group of nonusers of those categories matched for age, sex, study population and ponderosity. Women taking propranolol had a mean HDL cholesterol level 12 mg/dl lower than nonusers (p < 0.05). Men taking phenytoin had a mean HDL cholesterol level more than 18 mg/dl higher than nonusers (p < 0.05). Men taking benzodiazepine derivatives had a mean HDL cholesterol level 3.3 mg/dl lower than nonusers (p < 0.05). No significant differences were found between users and nonusers of thiazide diuretics, chlorthalidone, barbiturates, sympathomimetics or antihistamines.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Barbiturates / therapeutic use
  • Benzodiazepines / therapeutic use
  • Benzothiadiazines
  • Chlorthalidone / therapeutic use
  • Cholesterol / blood*
  • Diuretics
  • Female
  • Histamine H1 Antagonists / therapeutic use
  • Humans
  • Lipoproteins, HDL / blood*
  • Lipoproteins, LDL / blood
  • Male
  • Phenytoin / therapeutic use
  • Propranolol / therapeutic use
  • Sodium Chloride Symporter Inhibitors / therapeutic use
  • Sympathomimetics / therapeutic use
  • Triglycerides / blood

Substances

  • Barbiturates
  • Benzothiadiazines
  • Diuretics
  • Histamine H1 Antagonists
  • Lipoproteins, HDL
  • Lipoproteins, LDL
  • Sodium Chloride Symporter Inhibitors
  • Sympathomimetics
  • Triglycerides
  • Benzodiazepines
  • Phenytoin
  • Cholesterol
  • Propranolol
  • Chlorthalidone